SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Maternal-Fetal Medicine Referral — Charlotte Brontë — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Charlotte Brontë |
|---|
| Date of birth | 1816-04-21 |
|---|
| Identifiers | MRN HR-NI025-SYN-TD; SSN (made up) 000-25-3804 |
|---|
| Document date | 1855-01-13 |
|---|
| Author | Eleanor Thwaite, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
First pregnancy at 38, at 7 weeks 1 day by today's dating scan, with moderate nausea and vomiting for a week and early weight loss. Please advise on the plan if it worsens, on aneuploidy screening and diagnostic options at her age, on preeclampsia prevention, and on her tuberculosis risk. [S]
Urgency: Soon, within one to two weeks; same-day review here if she cannot keep fluids down. [S]
Questions for the consultant:
- What escalation plan do you advise if her nausea and vomiting worsens, including the thresholds for intravenous fluids or admission and the place of ondansetron before 10 weeks?
- What aneuploidy screening and diagnostic options should we offer at 38, and when?
- Does she need low-dose aspirin for preeclampsia prevention, and from when?
- How should we interpret and act on her family history of tuberculosis in pregnancy?
- What else should the plan for the rest of this pregnancy include because of her age?
History of Present Illness
Ms. Brontë is a 38-year-old novelist, married seven months, in a planned first pregnancy with a single live intrauterine pregnancy measuring 7 weeks 1 day. Nausea most of the day and vomiting three or four times a day began a week ago; PUQE-24 score 10 (moderate). She weighs 45.1 kg, 2 percent below her pre-pregnancy 46.0 kg (height 152 cm). Blood pressure 104/66 mmHg, pulse 84. Sodium 137, potassium 3.9 mmol/L, creatinine 0.52 mg/dL, hemoglobin 12.8 g/dL; urine ketones 15 mg/dL. She starts doxylamine-pyridoxine two tablets at bedtime today, with folic acid in place of her iron-containing prenatal vitamin. Her mother died young after a long illness, two elder sisters died of tuberculosis in childhood, and two more sisters died of tuberculosis as young adults, in her household; an interferon-gamma release assay was sent today with the first prenatal tests. PHQ-9 5. She received the influenza vaccine today. No medical history of note and no allergies [S]
- Nausea most of the day for a week and vomiting three or four times a day; she can no longer face meals and has lost about a kilogram. [S]
- She is glad of the pregnancy but anxious about her age and about her own health, having lost her mother and her sisters young. [S]
- She asks whether she could carry tuberculosis, since it was in her household. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Charlotte Brontë was born on 21 April 1816 in Thornton, Yorkshire, the third of six children of Maria Branwell and her husband, an Anglican clergyman. [D]
- Jane Eyre was first published in 1847 under the pseudonym Currer Bell. [D]
- Her mother died on 15 September 1821, in the 39th year of her age, after a long and painful illness. [D]
- Her mother's illness may have been cancer; one reference work says uterine cancer. The cause is a later interpretation. [R]
- Her two elder sisters, Maria and Elizabeth, fell ill at the Clergy Daughters' School at Cowan Bridge and died at home in 1825, Maria on 6 May aged 11 and Elizabeth on 15 June aged 10; reference works give tuberculosis. [D]
- Her brother Branwell died on 24 September 1848, aged 31, of several conditions made worse by heavy drinking; tuberculosis is listed among them. [D]
- Her sisters Emily and Anne died of tuberculosis, Emily on 19 December 1848 aged 30 and Anne on 28 May 1849 aged 29. [D]
- On 29 June 1854 she married Arthur Bell Nicholls, her father's curate, at Haworth. [D]
- In late November 1854, after a long walk on the moors to a waterfall that ended in heavy rain, she began to shiver and had a bad lingering sore throat and cold that made her thin and weak. [D]
- Early in 1855, after a visit to Gawthorpe and a long walk over damp ground in thin shoes, she was attacked by "new sensations of perpetual nausea, and ever-recurring faintness"; a doctor who was called assigned a natural cause for her indisposition. [D]
10 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Folic acid 0.4 mg oral tablet, one tablet by mouth daily (replacing an iron-containing prenatal vitamin while nausea is severe) | One tablet by mouth daily | Oral route | 1855-01-13 | active | S |
| Doxylamine 10 mg and pyridoxine 10 mg delayed-release tablet, two tablets by mouth at bedtime | Two tablets by mouth at bedtime | Oral route | 1855-01-13 to 1855-01-20 | completed | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| First pregnancy at 38 (elderly primigravida), single live intrauterine pregnancy dated by ultrasound at 7 weeks 1 day | active | confirmed |
O09.519 | S — Synthetic modern prenatal care anchored to the documented report that she was pregnant when she died; the pregnancy itself is questioned in one source (CLM-0019). |
| Nausea and vomiting of pregnancy, moderate (PUQE-24 score 10), with early weight loss, under evaluation for hyperemesis gravidarum | active | confirmed |
O21.9 | S — Synthetic presenting concern at the index visit, superseded by the hyperemesis gravidarum diagnosis at the sick visit; her documented "perpetual nausea" is D and the hyperemesis reading of it is R. |
Past Medical History
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|
| November 1854 | A bad lingering sore throat and cold after a long walk in heavy rain on the moors, which made her thin and weak | D (CLM-0009) |
Family History
| Relative | Condition | Age at death | Evidence |
|---|
| mother | Died in 1821 in her 39th year after a long and painful illness, possibly cancer | | R (CLM-0003, CLM-0004) |
| sister | Eldest sister: tuberculosis after illness at boarding school; died in 1825 aged 11 | 11 | D (CLM-0005) |
| sister | Second sister: tuberculosis after illness at boarding school; died in 1825 aged 10 | 10 | D (CLM-0005) |
| brother | Died in 1848 aged 31 of several conditions made worse by heavy drinking, with tuberculosis among them | 31 | D (CLM-0006) |
| sister | Tuberculosis; died in 1848 aged 30 | 30 | D (CLM-0007) |
| sister | Tuberculosis; died in 1849 aged 29 | 29 | D (CLM-0007) |
Social History
- Occupation: novelist who writes at home in the mornings; her most recent novels were widely read [S]
- Married seven months ago; lives with her husband and her elderly father in a stone house beside the church at the edge of the moors; neither is named in this record; the pregnancy was planned and is wanted [S]
- Never smoked; no alcohol since before conception; no drug use; one cup of tea a day [S]
- Walked on the moors most days until the nausea began; feels safe at home, and the screen for intimate partner violence is negative [S]
- Supports: her husband, a close friend from school days with whom she writes often, and the household's long-serving help [S]
Vital Signs
| Date | Measure | Value | Unit | Provenance |
| 1855-01-13 | Body height | 152 | cm | S |
| 1855-01-13 | Body weight | 45.1 | kg | S |
| 1855-01-13 | Body mass index (BMI) [Ratio] | 19.5 | kg/m2 | S |
| 1855-01-13 | Systolic blood pressure | 104 | mm[Hg] | S |
| 1855-01-13 | Diastolic blood pressure | 66 | mm[Hg] | S |
| 1855-01-13 | Heart rate | 84 | /min | S |
| 1855-01-13 | Respiratory rate | 14 | /min | S |
| 1855-01-13 | Body temperature | 36.7 | Cel | S |
| 1855-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 1855-01-13 | Hemoglobin [Mass/volume] in Blood | 12.8 | g/dL | 11-15.5 g/dL | Normal | S |
| 1855-01-13 | Leukocytes [#/volume] in Blood by Automated count | 8.4 | 10*3/uL | 4-13 10*3/uL | Normal | S |
| 1855-01-13 | Platelets [#/volume] in Blood by Automated count | 248 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 1855-01-13 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 1855-01-13 | Potassium [Moles/volume] in Serum or Plasma | 3.9 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1855-01-13 | Chloride [Moles/volume] in Serum or Plasma | 102 | mmol/L | 98-107 mmol/L | Normal | S |
| 1855-01-13 | Carbon dioxide, total [Moles/volume] in Serum or Plasma | 24 | mmol/L | 22-29 mmol/L | Normal | S |
| 1855-01-13 | Urea nitrogen [Mass/volume] in Serum or Plasma | 8 | mg/dL | 6-20 mg/dL | Normal | S |
| 1855-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.52 | mg/dL | 0.4-0.9 mg/dL | Normal | S |
| 1855-01-13 | Glucose [Mass/volume] in Serum or Plasma | 76 | mg/dL | 70-99 mg/dL | Normal | S |
| 1855-01-13 | Ketones [Mass/volume] in Urine by Test strip | 15 | mg/dL | <=0 mg/dL | High | S |
| 1855-01-13 | Fetal Crown Rump length US | 11 | mm | Consistent with 7 weeks 1 day by the last menstrual period | Normal | S |
| 1855-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | | | S |
Assessment
- First pregnancy at 38 (elderly primigravida), single live intrauterine pregnancy dated by ultrasound at 7 weeks 1 day: active, confirmed [S]
- Nausea and vomiting of pregnancy, moderate (PUQE-24 score 10), with early weight loss, under evaluation for hyperemesis gravidarum: active, confirmed [S]
Plan of Treatment
- First prenatal visit: dating ultrasound; blood count, blood group and antibody screen, rubella immunity, hepatitis B surface antigen, HIV, syphilis, and hepatitis C tests; urine culture; metabolic panel and urinalysis because of vomiting; influenza vaccine; folic acid 0.4 mg daily in place of the iron-containing prenatal vitamin while nausea lasts. Guideline: USPSTF A and B Recommendations (2026); Guidelines for Vaccinating Pregnant Persons (2026) [S]
- Nausea and vomiting, step by step: small frequent dry meals, fluids between meals, ginger if she wishes, and avoiding smells that trigger nausea; doxylamine-pyridoxine from today, raised to four tablets a day if needed; then a second drug (metoclopramide, promethazine, or ondansetron after counseling); PUQE-24 score, weight, pulse, blood pressure, and electrolytes at each visit; same-day review if she cannot keep fluids down for 24 hours or loses more than 5 percent of her pre-pregnancy weight. Guideline: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024) [S]
- Aneuploidy screening offered to all, with diagnostic testing available: cell-free DNA from 10 weeks, a nuchal translucency scan at 11 to 14 weeks, or chorionic villus sampling or amniocentesis; a detailed anatomy scan at 18 to 22 weeks. Guideline: Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226 (2020) [S]
- Tuberculosis screening with an interferon-gamma release assay because of tuberculosis deaths in her household; a shielded chest radiograph and treatment decisions only if it is positive. Guideline: Latent Tuberculosis Infection in Adults: Screening (2023) [S]
- Mental health: PHQ-9 at intake and the EPDS in each trimester and after any admission, with support for the strain of severe vomiting and for anxiety rooted in family loss. Guideline: Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum (Clinical Practice Guideline No. 4) (2023); Perinatal Depression: Preventive Interventions (2019) [S]
- Preeclampsia prevention: low-dose aspirin 81 mg at bedtime from 12 to 16 weeks until delivery if she has one high-risk or more than one moderate-risk factor (she has two: first pregnancy and age 35 or older); blood pressure at every visit. Guideline: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication (2021) [S]
- Monitoring while nausea and vomiting last: PUQE-24, weight, pulse, and blood pressure at every visit; electrolytes until stable on oral intake; liver tests if abnormal; mood each trimester; antiemetic side effects (drowsiness, restlessness or abnormal movements, constipation, palpitations). Guideline: ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy (2018); The Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum (Green-top Guideline No. 69) (2024) [S]
- Referral to maternal-fetal medicine, Margaret Oyelaran-Hughes, MD, ordered 1855-01-13 [S]